drugset / Trial / NCT02110342
A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The Body
NaSingle-groupOpen-labelBasic science
Summary
The study aims to understand, using radiolabelled PF-04449913, how this compound is modified by the body once it is absorbed. The study also aims to understand how much of the compound is broken down and how much leaves the body unchanged.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glasdegib | Small molecule | 100 mg | Oral |
| Subject | Glasdegib | Small molecule | 100 unknown | Oral |
Indications
No indication recorded.